Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19

Elena Nabieva, Andrey B. Komissarov, Galya V. Klink, Stanislav V. Zaitsev, Maria Sergeeva, Artem V. Fadeev, Kseniya Komissarova, Anna Ivanova, Maria Pisareva, Kira Kudrya, Daria Danilenko, Dmitry Lioznov, Ryan Hisner, Federico Gueli, Thomas P. Peacock, Cornelius Roemer, Georgii A. Bazykin
doi: https://doi.org/10.1101/2023.09.14.23295379
Elena Nabieva
1A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrey B. Komissarov
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Galya V. Klink
1A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia
3Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanislav V. Zaitsev
4Kaluga Regional Specialized Centre for Infectious Diseases and AIDS, Kaluga, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Sergeeva
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Artem V. Fadeev
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kseniya Komissarova
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Ivanova
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Pisareva
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kira Kudrya
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daria Danilenko
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dmitry Lioznov
2Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Hisner
5University of Cape Town, Rondebosch, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federico Gueli
6Independent researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas P. Peacock
7Department of Infectious Disease, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelius Roemer
8Biozentrum, University of Basel, Basel, Switzerland
9Swiss Institute of Bioinformatics, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgii A. Bazykin
1A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yegor.bazykin{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We report the genomic analysis of a highly divergent SARS-CoV-2 sample obtained in October 2022 from an HIV+ patient with presumably long-term COVID-19 infection. Phylogenetic analysis indicates that the sample is characterized by a gain of 89 mutations since divergence from its nearest sequenced neighbor, which had been collected in September 2020 and belongs to the B.1.1 lineage, largely extinct in 2022. 33 of these mutations were coding and occurred in the Spike protein. Of these, 17 are lineage-defining in some of the variants of concern (VOCs) or are in sites where another mutation is lineage-defining in a variant of concern, and/or shown to be involved in antibody evasion, and/or detected in other cases of persistent COVID-19; these include some “usual suspects,” such as Spike:L452R, E484Q, K417T, Y453F, and N460K. Molecular clock analysis indicates that mutations in this lineage accumulated at an increased rate compared to the ancestral B.1.1 strain. This increase is driven by the accumulation of nonsynonymous mutations, for an average dN/dS value of 2.2, indicating strong positive selection during within-patient evolution. Additionally, there is reason to believe that the virus had persisted for at least some time in the gastrointestinal tract, as evidenced by the presence of mutations that are rare in the general population samples but common in samples from wastewater. Our analysis adds to the growing body of research on evolution of SARS-CoV-2 in chronically infected patients and its relationship to the emergence of variants of concern.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work has been supported by the RSF grant no 21-74-20160 to GVK.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The research was approved by the Local Ethics Committee of Smorodintsev Research Institute of Influenza (protocol No. 203, 18 May 2023)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are available in GISAID with the identifier EPI_ISL_15829108.

https://gisaid.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 17, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19
Elena Nabieva, Andrey B. Komissarov, Galya V. Klink, Stanislav V. Zaitsev, Maria Sergeeva, Artem V. Fadeev, Kseniya Komissarova, Anna Ivanova, Maria Pisareva, Kira Kudrya, Daria Danilenko, Dmitry Lioznov, Ryan Hisner, Federico Gueli, Thomas P. Peacock, Cornelius Roemer, Georgii A. Bazykin
medRxiv 2023.09.14.23295379; doi: https://doi.org/10.1101/2023.09.14.23295379
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19
Elena Nabieva, Andrey B. Komissarov, Galya V. Klink, Stanislav V. Zaitsev, Maria Sergeeva, Artem V. Fadeev, Kseniya Komissarova, Anna Ivanova, Maria Pisareva, Kira Kudrya, Daria Danilenko, Dmitry Lioznov, Ryan Hisner, Federico Gueli, Thomas P. Peacock, Cornelius Roemer, Georgii A. Bazykin
medRxiv 2023.09.14.23295379; doi: https://doi.org/10.1101/2023.09.14.23295379

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1191)
  • Hematology (431)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4927)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (725)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4215)
  • Public and Global Health (7506)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)